18 June 2025 - National health care institute Zorginstituut Nederland has scrapped several cancer inhibiting drugs from the basic health ...
19 June 2025 - NICE is unable to make a recommendation on the use of tislelizumab (Tevimbra) for the treatment of ...
19 June 2025 - NICE has published final evidence-based recommendations on the use of atezolizumab (Tecentriq) for the adjuvant treatment ...
16 June 2025 - With the addition of 12.5 mg and 15 mg vials, all approved doses of Zepbound will be ...
17 June 2025 - Kye Pharmaceuticals today announced that Health Canada has approved its supplemental new drug submission regarding the recommended ...
18 June 2025 - Health Canada approval is based on the pivotal Phase 3 NATALEE trial data, which demonstrated a clinically ...
16 June 2025 - Associate Health Minister David Seymour says the oestradiol patch funding decision is an example of PHARMAC’s ...
16 June 2025 - PHARMAC will fund two brands of oestradiol patches – Estradot and Estradiol TDP Mylan – from ...
17 June 2025 - The US FDA today announced its Commissioner’s National Priority Voucher program to enhance the health interests of ...
17 June 2025 - Aldeyra Therapeutics today announced the resubmission of a new drug application to the US FDA for ...
18 June 2025 - Today, the FDA approved tafasitamab-cxix (Monjuvi, Incyte) with lenalidomide and rituximab for adults with relapsed or ...
18 June 2025 - Approval based on Phase 3 PURPOSE 1 and PURPOSE 2 data that showed ≥99.9% of participants remained ...
18 June 2025 - Bavarian Nordic announced today that it has entered into an agreement to sell its priority review ...
13 June 2025 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
10 June 2025 - Duke Street Bio today announced that the US FDA has granted fast track designation to DSB2455, its ...